left_gutter_top
Twinject Home - Patients and CaregiversLearn More About TwinjectTwinject Training & InstructionsSevere Allergies & AnaphylaxisPatient Resources - Tools & FAQsPrescribing InformationFor Healthcare Professionalstopnav_endcap
Refill Reminders Locate an Allergy Specialist Create an Action Plan Download Allergy Alert Cards View Cases, Holders & Carriers Sign Up for News & Offers FAQs & Links
Patient Resources Tools & FAQs
Cases, Holders, and Carriers for Twinject®

Twinject® is the only available auto-injector that provides 2 doses of epinephrine in 1 device. Portable, lightweight Twinject® frees you from the hassle of keeping track of 2 separate auto-injectors, and allows you to replace bulky travel packs with 1 slim carrying case.

Twinject 2-doses-in-1 auto-injector with a free carrying case.

Simple assurance in a single handy case

At home, at school, or on the road, Twinject's® sturdy and convenient carrying case ensures that your auto-injector stays protected at all times. Lightweight and crush-resistant, the Twinject® case also helps protect the drug from sunlight. Each slim, low-profile case also features a handy clip for attaching to pockets or bags.

In addition to Twinject's® custom carrying case, a variety of other carrying cases are available for purchase online. Below is a list of cases designed to accommodate Twinject® auto-injectors. Verus offers these links as a service to our customers, but cannot guarantee quality, prices, or services for items purchased.

Learn more about Twinject® 2-doses-in-1 auto-injector with a free carrying case.

EpiPen is a registered trademark of Dey LP. Anapen is a registered trademark of Lincoln Medical Ltd. Ana-Tote is a registered trademark of Aero Pharmaceuticals, Inc. Medipouch is a registered trademark of Patricia A. Gilbert.

verus_logo
Privacy Policy | Terms of Use | Newsroom | Sitemap | Contact Verus

IMPORTANT SAFETY INFORMATION ABOUT TWINJECT: Twinject is indicated in the emergency treatment of severe allergic reaction (type I) including anaphylaxis to stinging insects and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as anaphylaxis to unknown substance or exercise-induced anaphylaxis.

Since the dose of epinephrine delivered from Twinject 0.15 mg is fixed at 0.15 mg, the physician should consider other forms of injectable epinephrine if doses lower than 0.15 mg are felt to be necessary (eg, patients who weigh less than 15 kilograms [approximately 33 pounds]).

Twinject should only be injected into the anterolateral aspect of the thigh. Accidental injection into the hands or feet may result in loss of blood flow to the affected area and should be avoided. DO NOT INJECT INTO BUTTOCK. DO NOT INJECT INTRAVENOUSLY.

Epinephrine should be administered with caution to patients with cardiac arrhythmias, coronary artery or organic heart disease, or hypertension. In patients with coronary insufficiency or ischemic heart disease, epinephrine may precipitate or aggravate angina pectoris as well as produce ventricular arrhythmias. It should be recognized that the presence of these conditions is not a contraindication to epinephrine administration in an acute Life-threatening situation. Adverse reactions to epinephrine include transient, moderate anxiety; apprehensiveness; restlessness; tremor; weakness; dizziness; sweating; palpitations; pallor; nausea and vomiting; headache; and/or respiratory difficulties.

Twinject is designed as an emergency supportive therapy only and is not a replacement or substitute for immediate medical care. Please see complete prescribing information for more details.